EUVIMEDEUVIMED entdecken
Crossref

Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke

Shu-Xian Lyu, Xue-Yan Cui, Shi-Xian Chen, Hai-Yan Shi, Xin Huang

Clinical Pharmacology in Drug Development · 2025

DOI: 10.1002/cpdd.1525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology in Drug Development, 2025. Verfasst von Shu-Xian Lyu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan,…. Hauptthemen laut MEDLINE: Ischemic Stroke, Benzofurans, Models, Biological. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butylphthalide is widely used to treat acute ischemic stroke in China, and the main adverse effect is the increase in transaminase levels. We aimed to establish a population pharmacokinetic model of butylphthalide in elderly patients with ischemic stroke and identified covariates influencing butylphthalide pharmacokinetics. We collected butylphthalide blood samples via opportunistic sampling. We chose the base model, compared 1‐, 2‐, and 3‐compartment models, and used basic patient information, laboratory test results, concomitant drugs, and comorbidities as covariates to examine our study. Our study included 50 patients (n = 106 blood samples), and a 2‐compartment model with first‐order elimination matched the experimental data well. Body weight and comorbid diabetes significantly affect the clearance of butylphthalide. On the basis of the final PPK model, the Monte Carlo method was used to compare the effects of different body weights and the state of diabetes on the steady‐state area under the concentration–time curve at 0‐24 hours. The results revealed that the steady‐state area under the concentration–time curve at 0‐24 hours was lower in patients with diabetes than in patients without diabetes, and both values decreased with weight gain. Our findings provide information for personalized treatment plans for patients with ischemic stroke (aged 65 years or older) receiving butylphthalide injection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeBenzofuransModels, BiologicalHumansAgedMaleFemaleAged, 80 and overChinaMiddle AgedBody WeightMonte Carlo MethodArea Under CurveDiabetes MellitusAge FactorsEast Asian People

Stichwörter der Autor:innen

butylphthalide injectionclinical pharmacologyischemic strokepopulation pharmacokineticstherapeutic drug monitoring

Substanzen

3-n-butylphthalideBenzofurans

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
  • Department of Pharmacy, Linyi People's Hospital, Linyi, China.
  • School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Zitieren

APA

Lyu, S. X., Cui, X. Y., Chen, S. X., Shi, H. Y., & Huang, X. (2025). Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1525

Vancouver

Lyu SX, Cui XY, Chen SX, Shi HY, Huang X. Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke. Clinical Pharmacology in Drug Development. 2025. doi:10.1002/cpdd.1525

BibTeX
@article{Lyu2025,
  author = {Lyu, Shu-Xian and Cui, Xue-Yan and Chen, Shi-Xian and Shi, Hai-Yan and Huang, Xin},
  title = {Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2025},
  doi = {10.1002/cpdd.1525}
}
Kostenlos starten →